Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:tapinarof
|
| gptkbp:age |
adults
|
| gptkbp:approvalYear |
2022
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
D05AX
|
| gptkbp:form |
topical cream
|
| gptkbp:frequency |
once daily
|
| https://www.w3.org/2000/01/rdf-schema#label |
VTAMA cream
|
| gptkbp:indication |
plaque psoriasis
|
| gptkbp:manufacturer |
gptkb:Dermavant_Sciences
|
| gptkbp:mechanismOfAction |
aryl hydrocarbon receptor agonist
|
| gptkbp:powers |
1%
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
gptkb:contact_dermatitis
gptkb:folliculitis headache pruritus pain at application site |
| gptkbp:bfsParent |
gptkb:Dermavant_Sciences
|
| gptkbp:bfsLayer |
6
|